Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Protocol for the Prospective Evaluation of a Commercially Available Hydrogel Spacer

NCT05323747 is registered in ClinicalTrials.gov with BioProtect as lead sponsor.

NCT NCT05323747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05323747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Protocol for the Prospective Evaluation of a Commercially Available Hydrogel Spacer
Lead sponsor
BioProtect
Phase
Observational
Overall status
Completed
Start date
November 20, 2020
Completion date
February 8, 2022
Enrollment
20 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer